Table of Contents:
  • Examples of in vitro-in vivo relationships with a diverse range of quality
  • Dissolution assay development for in vitro-in vivo correlations: theory and case studies
  • In vitro dissolution profile comparison and IVIVR: carbamazepine case
  • A general framework for non-parametric subject-specific and population deconvolution methods for in vivo-in vitro correlation
  • Convolutin-based approaches for in vivo-in vitro correlation modeling
  • Approaches to IVIVR modelling and statistical analysis
  • Validation of in vitro-in vivo correlation models
  • Examples of developing in vitro-in vivo relationships
  • The biopharmaceutic drug classification and drugs administered in extended release (ER) formulations
  • Investigating in vitro drug release mechanisms inside dosage forms: monitoring liquid ingress in HPMC hydrophilic matrices using confocal microscopy
  • Determinatin of critical manufacturing and formulatin variables for a hydrophilic matrix tablet formulatin using an in vitro discriminatroy dissolution method
  • Artificial neural network based in vitro-in vivo correlations
  • Setting dissolution specificatins for modified-release dosage forms
  • Review of methodologies for the comparison of dissolution profile data
  • Assessing whether controlled release products with differing in vitro dissolution rates have the same in vivo-in vitro relationship
  • Comparison of methodologies for evaluating regional intestinal permeability
  • In vitro-in vivo relationships of several "immediate" release tablets
  • Nonlinear in vitro-in vivo correlations
  • Use of nonlinear mixed effects modelling in the development of in vitro-in vivo correlations
  • The development of a novel in vitro discriminatory dissolution method for a class I drug in a matrix tablet formulation
  • In vivo-in vitro evaluation of the impact of accelerated stability conditions on a hydrophilic matrix tablet
  • Development of in vitro-in vivo correlations using various artificial neural network configurations
  • Impact of IVIVR on product development
  • The role of in vitro-in vivo correltions (IVIVC) to regulatory agencies
  • Draft guidance for industry extended-release solid oral dosage forms: development evaluation and application of in vitro-in vivo correlations
  • Issues important to in vitro-in vivo correlation: IVIVR workshop open discussion.